EFTA02668783

From: Sent: To: Subject: neurontin On Thu, Dec 1, 2016 at 11:41 PM, y jeffrey E. <[email protected]> Friday, December 2, 2016 4:45 AM Re: » wrote: On Dec 1, 2016, at 8:12 PM, jef=rey E. <[email protected] <mailto:[email protected]> wrote: for you? On Thu, Dec 1, 2016 at 11:02 PM, Are you aware of any new, effective migraine treatments? =/cliv> please note<=r> The information contained in this communication is confidential,=may be attorney-client privileged, may constitute inside information, a=d is intended only for the use of the addressee. It is the property of<=r>JEE Unauthorized use, disclosure or copying of this communication =r any part thereof is strictly prohibited and may be unlawful. If you h=ve received this communication in error, please notify us immediately b= return e-mail or by e-mail to [email protected] <mailto:[email protected]> , and destroy this communica=ion and all copies thereof, including all attachments. copyright -all r=ghts reserved EFTA_R1_01921022 EFTA02668783 please note Th= information contained in this communication is confidential, may be at=orney-client privileged, may constitute inside information, and is inte=ded only for the use of the addressee. It is the property of JEE =nauthorized use, disclosure or copying of this communication or any par= thereof is strictly prohibited and may be unlawful. If you have receiv=d this communication in error, please notify us immediately by retur= e-mail or by e-mail to [email protected] <mailto:[email protected]> , and destroy this communication and a=l copies thereof, including all attachments. copyright -all rights rese=ved 2 EFTA_R1_01921023 EFTA02668784